← Back to Search

Smartwatch Monitoring for Respiratory Diseases

N/A
Recruiting
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Broken, damaged or irritated skin or rashes near the sensor application sites
History of active (clinically significant) skin disorders
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will study how a smartwatch device can help monitor and detect respiratory disease flare-ups, offering people with the disease more freedom and better care.

Who is the study for?
This trial is for adults over 18 fluent in English with lung diseases like COPD, interstitial lung disease, or pulmonary hypertension. Healthy individuals can also join. Participants must be able to use the Health Gauge wearable device and sign consent. Excluded are pregnant individuals, those with electronic implants, significant daily living activity impairment, skin issues near sensor sites, or allergies to plastic.
What is being tested?
The study tests the Health Gauge Phoenix AI-based Smart Watch's ability to monitor vital signs and physical activities continuously at home. It aims to prove long-term comfort of use, safety, and potential in detecting exacerbations earlier than current methods.
What are the potential side effects?
Since this trial involves a non-invasive wearable device monitoring health parameters without medications or invasive procedures involved, side effects may include discomfort from wearing the device or skin irritation at the site of application.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have broken or irritated skin near where the device would be placed.
Select...
I have a significant ongoing skin condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Length of time wearing device
Secondary study objectives
Adverse Events
Prediction of respiratory exacerbations- Number of emergency room visits or hospitalizations

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Device: Health Gauge AI-Based Wearable Device - Model: PhoenixExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
921 Previous Clinical Trials
431,774 Total Patients Enrolled
~27 spots leftby Apr 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top